接受化疗的血液病患者疫苗接种覆盖率:是否应转向个体化疫苗接种?
本研究调查接受化疗的血液病患者流感、肺炎球菌和dTP疫苗接种覆盖率及影响因素,发现覆盖率不理想,流感45-56%、dTP44%、IPD16-19%,与ECIL7指南符合率流感63%、IPD87%,患者信息告知和血液科医生推荐与接种正相关。
要点
- 接受化疗的血液病患者流感、dTP和IPD疫苗接种覆盖率均不理想。
- 患者信息告知与流感及IPD接种正相关,血液科医生推荐与肺炎球菌接种正相关。
- 建议所有医疗参与者采取主动态度,提供患者信息和个体化疫苗接种计划。
核心结论
- 尽管存在接种机会,特定推荐的复杂性和卫生参与者之间沟通不足可能导致该高危人群疫苗接种覆盖率不理想。
- 作者认为,所有城市和医院参与者采取主动态度,包括更好的患者信息和个体化且不断更新的疫苗接种计划以帮助全科医生协调接种,将有助于提高疫苗覆盖率。
研究设计与样本
- 在血液科日间医院向所有患者发放调查问卷,评估疫苗接种情况和一般看法。
- 从医疗和疫苗接种记录中收集疫苗接种种数;通过电话评估每位全科医生对免疫抑制患者疫苗接种的知识和态度。
- 根据ECIL7指南评估疫苗接种与接种指征的符合性,采用多变量逻辑回归评估与接种相关的因素。
主要发现
- 145例患者中,66%年龄≥65岁,40%随访淋巴瘤,38%随访多发性骨髓瘤,39%接受抗CD20抗体治疗。
- 流感疫苗接种覆盖率为45-56%,dTP为44%,IPD为16-19%,不同信息来源的覆盖率差异大(19-76%)。
- 与ECIL7推荐的符合率流感为63%,IPD为87%。
- 患者获得特定疫苗接种信息与流感和IPD接种正相关;对疫苗接种持积极态度和年龄≥65岁与流感接种正相关;血液科医生推荐与肺炎球菌接种正相关。
临床怎么用
- 作者建议所有城市和医院参与者采取主动态度,包括更好的患者信息和个体化且不断更新的疫苗接种计划以帮助全科医生协调接种,以提高疫苗覆盖率。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Immunocompromised patients are at high-risk for severe influenza and invasive pneumococcal diseases (IPD). Despite the French Public Health Council (FPHC) and the 7th European Conference on Infections in Leukaemia (ECIL7) recommendations, vaccination coverage remains insufficient. This study aimed to estimate the coverage and determinants of influenza, pneumococcal and diphtheria-tetanus-poliomyelitis (dTP) vaccinations in hematological patients underlying chemotherapy. METHODS: A survey was distributed to all patients of the hematology day hospital assessing vaccine uptakes and general opinion about vaccination. Vaccine uptakes were collected from medical and vaccination records; knowledge of and attitudes towards vaccinations in immunocompromised patients were evaluated for each general practitioner (GP) by phone call. Adequacy between vaccine uptakes and indication or not to vaccinate according to ECIL7 guidelines was assessed. Factors associated with vaccine uptakes were assessed by multivariate logistic regression. RESULTS: Among 145 patients, 66 % were aged 65 years or older, 40 % were followed for lymphoma and 38 % for multiple myeloma, 39 % were treated with anti-CD20 antibodies. Vaccination coverage was suboptimal for influenza (45-56 %), dTP (44 %) and IPD (16-19 %) regardless of the guidelines followed, with a wide variation in rates by information source (19-76 %). Adequacy rate with ECIL7 recommendations were 63 % and 87 % for influenza and IPD respectively. Information of patients on specific vaccinations was positively associated with flu and IPD vaccinations, as well as favorable attitude toward vaccination and age ≥ 65 years for flu vaccination, and recommendation by hematologist for pneumococcal vaccination. CONCLUSION: Despite vaccination opportunities, the complexity of these specific recommendations and the lack of communication between the health actors could explain the suboptimal vaccination coverage in this high-risk population. A proactive attitude of all actors in the city and hospital, including better patient information and a personalized and evolving vaccination schedule to help GPs to coordinate vaccination would allow to improve vaccine coverage.
引用
- Pierron A, Bozon F, Berceanu A, et al. Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination? Vaccine. 2021. PMID: 34740475. doi:10.1016/j.vaccine.2021.10.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。